Toshiba rolls out ultrasound upgrade

Article

Toshiba American Medical Systems of Tustin, CA, last month introduced the next generation of its mid-range ultrasound scanners at the American College of Cardiology conference in New Orleans. PowerVision 6000edp (expanded digital performance) allows

Toshiba American Medical Systems of Tustin, CA, last month introduced the next generation of its mid-range ultrasound scanners at the American College of Cardiology conference in New Orleans. PowerVision 6000edp (expanded digital performance) allows users to select multifrequency tissue harmonics that best match the size of the patient and acoustic access, and incorporates technological advancements in Doppler performance and color maps for cardiac and vascular applications.

Other technologies available on the system include Toshiba’s version of harmonic imaging, called Flash Echo Imaging, and its latest version of Clear View Tissue Harmonics (CVTH). The company plans to provide the $30,000 PowerVision 6000edp as a free upgrade to facilities that already have PowerVision 6000 installed. Toshiba launched PowerVision 6000 last spring (SCAN 5/27/98).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.